Galapagos NV (GLPGF)

USD 26.26

(0.0%)

Long Term Debt Summary of Galapagos NV

  • Galapagos NV's latest annual long term debt in 2023 was 4.94 Million EUR , down -66.35% from previous year.
  • Galapagos NV's latest quarterly long term debt in 2024 Q1 was 3.83 Million EUR , down 0.0% from previous quarter.
  • Galapagos NV reported annual long term debt of 14.69 Million EUR in 2022, down -25.25% from previous year.
  • Galapagos NV reported annual long term debt of 19.65 Million EUR in 2021, down -14.67% from previous year.
  • Galapagos NV reported quarterly long term debt of 6.74 Million EUR for 2024 Q2, down 0.0% from previous quarter.
  • Galapagos NV reported quarterly long term debt of 9.2 Million EUR for 2023 Q2, down -9.91% from previous quarter.

Annual Long Term Debt Chart of Galapagos NV (2023 - 2004)

Historical Annual Long Term Debt of Galapagos NV (2023 - 2004)

Year Long Term Debt Long Term Debt Growth
2023 4.94 Million EUR -66.35%
2022 14.69 Million EUR -25.25%
2021 19.65 Million EUR -14.67%
2020 23.03 Million EUR 17.78%
2019 19.55 Million EUR 0.0%
2018 - EUR 0.0%
2017 - EUR -100.0%
2016 9000.00 EUR -85.71%
2015 63 Thousand EUR -45.22%
2014 115 Thousand EUR -31.14%
2013 167 Thousand EUR 1.21%
2012 165 Thousand EUR -63.41%
2011 451 Thousand EUR -47.98%
2010 867 Thousand EUR -10.06%
2009 964 Thousand EUR -16.61%
2008 1.15 Million EUR -33.83%
2007 1.74 Million EUR -61.98%
2006 4.59 Million EUR 0.0%
2005 - EUR 0.0%
2004 - EUR 0.0%

Peer Long Term Debt Comparison of Galapagos NV

Name Long Term Debt Long Term Debt Difference
Eiger BioPharmaceuticals, Inc. - USD -Infinity%
Nanobac Pharmaceuticals, Incorporated - USD -Infinity%
SQZ Biotechnologies Company 20.9 Million USD 76.355%
Evofem Biosciences, Inc. 8000.00 USD -61700.0%
Santhera Pharmaceuticals Holding AG 1.75 Million USD -181.633%
Mesoblast Limited 100.29 Million USD 95.071%
Propanc Biopharma, Inc. 58.64 Thousand USD -8330.818%
Genus plc 228.2 Million USD 97.833%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
CNBX Pharmaceuticals Inc. - USD -Infinity%
Marizyme, Inc. 667.12 Thousand USD -641.086%
ContraFect Corporation 2.21 Million USD -123.71%
Nymox Pharmaceutical Corporation - USD -Infinity%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 1.4 Million USD -252.404%
Intellipharmaceutics International Inc. - USD -Infinity%
AXIM Biotechnologies, Inc. 5.42 Million USD 8.891%
MultiCell Technologies, Inc. 36.43 USD -13571132.501%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 55.61 Million USD 91.11%
EV Biologics, Inc. - USD -Infinity%
Q BioMed Inc. - USD -Infinity%
Emmaus Life Sciences, Inc. 2.22 Million USD -122.102%
Neon Bloom, Inc. - USD -Infinity%
Mosaic ImmunoEngineering Inc. 1.22 Million USD -302.488%
Biomind Labs Inc. - USD -Infinity%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Pharming Group N.V. 166.1 Million USD 97.024%
Oncotelic Therapeutics, Inc. 1.89 Million USD -160.421%
Skye Bioscience, Inc. 171.23 Thousand USD -2787.345%
Therapeutic Solutions International, Inc. 5512.00 USD -89595.21%
THC Farmaceuticals, Inc. - USD -Infinity%
Arch Therapeutics, Inc. - USD -Infinity%
IMV Inc. 27.39 Million USD 81.955%
Acro Biomedical Co., Ltd. - USD -Infinity%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. 322 Thousand USD -1435.404%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
CSL Limited 11.23 Billion USD 99.956%
Halberd Corporation 150 Thousand USD -3196.0%
Enzolytics Inc. - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Affymax, Inc. - USD -Infinity%
SYBLEU INC 300 Thousand USD -1548.0%
Nuo Therapeutics, Inc. 164.2 Thousand USD -2910.871%
argenx SE 15.35 Million USD 67.8%
MetaStat, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 20.31 Million USD 75.66%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Arno Therapeutics, Inc. - USD -Infinity%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. - USD -Infinity%
Zenith Capital Corp. 4456.00 USD -110851.526%
Genscript Biotech Corporation 287.12 Million USD 98.278%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. 126.3 Thousand USD -3814.427%
WPD Pharmaceuticals Inc. 229.29 Thousand USD -2056.212%
American Oriental Bioengineering, Inc. 554.59 Thousand USD -791.469%
Provectus Biopharmaceuticals, Inc. 25.29 Thousand USD -19442.274%
Adynxx, Inc. - USD -Infinity%
Helix BioMedix, Inc. - USD -Infinity%
GlobeStar Therapeutics Corporation - USD -Infinity%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 8.26 Million USD 40.174%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
BioStem Technologies, Inc. 265.63 Thousand USD -1761.201%
ONE Bio Corp. 592.19 Thousand USD -734.856%
Reve Technologies, Inc. 1064.00 USD -464561.654%
Burzynski Research Institute, Inc. - USD -Infinity%
Wesana Health Holdings Inc. - USD -Infinity%
Agentix Corp. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
ProtoKinetix, Incorporated - USD -Infinity%
Regen BioPharma, Inc. 149.61 Thousand USD -3204.504%
Regen BioPharma, Inc. 149.61 Thousand USD -3204.504%
NovAccess Global Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. - USD -Infinity%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Kadimastem Ltd 229.69 Thousand USD -2052.457%
Oncology Pharma Inc. - USD -Infinity%
Institute of Biomedical Research Corp. - USD -Infinity%
CytoDyn Inc. 141 Thousand USD -3406.383%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Qrons Inc. 80 Thousand USD -6080.0%
Alseres Pharmaceuticals, Inc. 7.81 Million USD 36.777%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. 369.04 Thousand USD -1239.66%
International Stem Cell Corporation 445 Thousand USD -1011.011%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 8.15 Million USD 39.337%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. 457 Thousand USD -981.838%
Neutra Corp. - USD -Infinity%
Windtree Therapeutics, Inc. 1.16 Million USD -325.84%
PureTech Health plc 18.25 Million USD 72.91%
Coeptis Therapeutics, Inc. 150 Thousand USD -3196.0%
IXICO plc 275 Thousand USD -1697.818%
IntelGenx Technologies Corp. 11.83 Million USD 58.24%
Gelesis Holdings, Inc. 26.3 Million USD 81.208%
CSL Limited 11.23 Billion USD 99.956%
Cellectis S.A. 36.21 Million USD 86.347%